Shardaben Gulabdas Patel's Insider Trades & SAST Disclosures
Shardaben Gulabdas Patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Disposal of 31,400 Equity Shares done at an average price of Rs. 317.8 . Disclosure was reported to the exchange on March 14, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Shardaben Gulabdas Patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Disposal of 31,400 shares done . Disclosure was reported to the exchange on March 14, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharma | Shardaben Gulabdas Patel | Promoter | Disposal | 15 Mar 2022 | 31,400 | - | 0.16% | - | 11 Mar 2022 11 Mar 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Lincoln Pharma | Shardaben Gulabdas Patel | Promoter Group | Disposal | 14 Mar 2022 | 31,400 | 0 (0%) | 0.16% | 317.8 | 9,978,920 | 11 Mar 2022 11 Mar 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.